CClinicalTrials.gg
CompletedNCT04902092BEATUpdated Oct 23, 2023

Brain Exercise and Addiction Trial

An interventional study of High Intensity Interval Training and Strength and Resistance Training in Cannabis Use Disorder, Moderate and Cannabis Use Disorder, Severe, sponsored by Monash University. Completed at 1 site in Australia. Open to participants aged 20 Years to 55 Years. Per ClinicalTrials.gov, last updated 2023-10-23.

Sponsored by Monash University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 3 months after the study started (first participant enrolled Jan 2019, registered May 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Ages
20 Years to 55 Years
Sex
All
01

Study summary

Heavy cannabis use is associated with substantive learning and memory impairments and elevated risk of psychopathology. It has been repeatedly demonstrated that the hippocampus, centrally implicated in these processes, is particularly vulnerable to the deleterious effects of prolonged exposure to cannabis. This deterioration of hippocampal structure, function, and biochemistry can be reversed, but this requires two or more years of abstinence from cannabis. However, most heavy cannabis users find it extremely difficult to maintain abstinence over extended periods and current treatments for cannabis use disorders are inadequate. There is a pressing clinical need for an intervention that rapidly accelerates hippocampal recovery, ameliorates the associated cognitive impairments and mental health symptoms, and leads to improved treatment outcomes. One promising candidate is physical exercise. In addition to the well-known physical health benefits, regular exercise also has a potent positive effect on brain health. The current study will investitive the capacity of two different neuroscientifically-informed 12-week exercise programs can restore brain health for heavy long term cannabis users.

Read the detailed description

Heavy cannabis use is associated with substantive learning and memory impairments and elevated risk of psychopathology. It has been repeatedly demonstrated that the hippocampus, centrally implicated in these processes, is particularly vulnerable to the deleterious effects of prolonged exposure to cannabis. This deterioration of hippocampal structure, function, and biochemistry can be reversed, but this requires two or more years of abstinence from cannabis. However, most heavy cannabis users find it extremely difficult to maintain abstinence over extended periods and current treatments for cannabis use disorders are inadequate. There is a pressing clinical need for an intervention that rapidly accelerates hippocampal recovery, ameliorates the associated cognitive impairments and mental health symptoms, and leads to improved treatment outcomes. One promising candidate is physical exercise. In addition to the well-known physical health benefits, regular exercise also has a potent positive effect on brain health and can increase the size of the hippocampus. It's not yet known how much or what kind of exercise produces the best results. This study has been designed to compare the effects of two different exercise programs.

  1. 12 weeks of regular HIIT exercise
  2. 12 weeks of regular strength training

The research team are investigating whether the programs have a positive impact on brain health and, if they do, whether one is more effective than the other. The research team will also measure whether engaging in either program leads to a reduction in cannabis consumption, and improvements in thinking skills, mental health, and general wellbeing.

02

Conditions studied

  • Cannabis Use Disorder, Moderate
  • Cannabis Use Disorder, Severe

Browse trials for

03

In context

Marijuana Abuse

517 studies on the registry are indexed under Marijuana Abuse; 114 are open to participants now.

This study's enrollment of 65 is close to the median of 60 across 421 interventional studies indexed under Marijuana Abuse.

Browse Marijuana Abuse studies →

Lead sponsor

Monash University is the lead sponsor of 81 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Aged 20-55 years
  2. Voluntary and able to provide informed consent
  3. Fluent in English
  4. Current moderate - severe cannabis use disorder
  5. Major history of cannabis use (i.e. ≥3 days per week on average for ≥4 of the past 6 years)
  6. Capacity to tolerate physical exercise according to 'Fitness to Exercise'

Exclusion criteria

Exclusion Criteria:

  1. Have a history of cardiovascular disease, high blood pressure, musculoskeletal injury or other condition that would preclude safe engagement in VO2 max fitness testing and/or regular physical exercise
  2. Severe claustrophobia, non-MR compatible metallic implant, or other contraindication to MRI scanning
  3. Lifetime history of significant neurological illness, or moderate - severe brain injury,
  4. Current major unstable medical illness or chronic pain condition
  5. Lifetime history of schizophrenia, schizoaffective disorder, OCD, PTSD, bipolar disorder
  6. Current significant depression or anxiety that precludes ability to reliably engage in the exercise program
  7. Current moderate - severe substance use disorder for substances other than cannabis (excluding nicotine)
  8. Currently pregnant or lactating
  9. Shift work employment schedule within the prior 6-months
  10. Have engaged in ≥5 sessions of HITT or resistance training within the past 12-months
  11. History of treatment with antipsychotic medications
  12. Current participation in psychosocial treatment for substance use disorder
  13. Other psychoactive medications or psychosocial treatments will be considered on a case-by-case basis. Where a current psychoactive medication is deemed acceptable, both dose and type must have been stable for a minimum of four weeks prior to baseline assessment, and remain stable throughout the 12-week exercise phase of the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
65 participants (actual)

Study arms

  • Active comparator
    High Intensity Physical Training

    12-week, 36 session, cardiorespiratory-focussed physical exercise program delivered by an accredited exercise physiologist

    Behavioral: High Intensity Interval Training

  • Active comparator
    Low Intensity Physical Training

    12- week, 36 session, strength-focussed physical exercise program delivered by an accredited exercise physiologist

    Behavioral: Strength and Resistance Training

Interventions

  • BehavioralHigh Intensity Interval Training

    Exercise sessions will commence with an initial 3-week accustomization period whereby training load will increase incrementally from 2 x 45min sessions with effort peaking at 60% VO2 max (week 1) increasing to 3 x 45minute with effort peaking at 80% VO2max (week 3). Participants will transition to the full HIIT protocol for the remaining weeks. The HIIT component will comprise a work-rest ratio of ≥1:1minutes, with alternating exertion epochs at \>80% VO2max and \<60% VO2max. As VO2max is likely to increase as fitness improves toward the end of the 3-month program, adjustments to HIIT will be made by the exercise physiologist based on real-time heart rate monitoring, ensuring greater accuracy in participants achieving their heart rate targets.

  • BehavioralStrength and Resistance Training

    Exercise sessions will comprise a combination of strength, coordination and mobility exercises. The strength component will consist of 2-3 sets of resistance exercises at ≤70% of a predicted 1 repetition maximum, targeting all body segments. Heart rate tracking will occur to ensure participants do not exceed 70% v02 (or exceed Lactate Threshold).

06

What researchers measure

Primary outcomes

  1. Change in hippocampal integrity

    Composite score derived from three hippocampal health indices: volume (structural MRI), connectivity (DTI), neuronal health (MRS NAA) calculated as described in Yucel et al (2016), doi:10.1038/tp.2015.201.

    Time frame: Baseline (0 months), post (3 months)

Secondary outcomes

  1. Change in cannabis use

    Time line follow back

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  2. Change in cannabis dependence

    Severity of Dependence Scale (SDS; range = 0-15 higher scores indicate higher dependence

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  3. Change in cannabis craving

    Penn Craving Scale (PCS; range = 0 - 30 higher scores indicate greater craving)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  4. Change in depression symptoms

    Quick Inventory of Depressive Symptomology (QUIDS; range = 0 - 27 higher scores indicate greater depression symptom severity)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  5. Change in anxiety symptoms

    StateTrait Anxiety Inventory (STAI; range = 20 to 80, higher scores indicate greater anxiety)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  6. Change in resilience

    Connor David Resilience Scale (CDRS; range = 0-100 higher scores indicate higher resilience)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  7. Change in coping skills

    Perceived Stress Scale (10 item; range = 0 - 40 higher scores indicate greater stress)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  8. Change in sleep quality

    Pittsburgh Sleep Quality Index (PSQI; range = 0 to 21 higher scores indicate worse sleep quality)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  9. Change in mental wellbeing

    Warwick Edinburgh Mental Wellbeing Scale (WEMWBS; range = 14-70 higher scores indicate increased mental well being)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  10. Change in quality of life

    Quality of Life and Satisfaction Questionnaire - Short Form (QOL-SF; range = 70 higher scores indicate greater life satisfaction and enjoyment)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  11. Change in memory

    Rey Auditory Verbal Learning Test (RAVLT)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  12. Change in associative memory

    Paired Associates Learning Task (PAL)

    Time frame: Baseline (0 months), post (3 months), follow up (6 months)

  13. Change in visual memory

    Figural Memory Tasks

    Time frame: Baseline (0 months), post (3 months)

  14. Change in cardiorespiratory fitness

    VO2 max

    Time frame: Baseline (0 months), post (3 months)

07

Study locations

1 site
  • Monash University, BrainPark
    Melbourne, Victoria 3800, Australia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04902092
Lead sponsor
Monash University
Collaborators
Turning Point
Responsible party
Rebecca Segrave (Senior Research Fellow, Monash University) — Principal investigator
First posted
May 26, 2021
Start date
Jan 23, 2019
Primary completion
Jun 10, 2022
Completion
Nov 21, 2022
Last update
Oct 23, 2023

Study contacts

Murat Yucel
principal investigator · Monash University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion